Ultragenyx

Ultragenyx

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$17.04
Previous Close
$16.63
Day Range
$16.30-$17.63
52W Range
$12.73-$39.88
Market Cap
$1.6B
Shares Short
20M

Financials

See more
Revenue (12 Mos)
$717M
Revenue Growth (YoY)
28.1%
Gross Profit (12 Mos)
-$149M
Diluted EPS
-$5.82

News

See more

Yahoo Finance • 11 hours ago

Ultragenyx Pharmaceutical (RARE) Recasts The Story After FDA Approvals As Valuation Debate Builds

Yahoo Finance • last month

FDA Approves Fayuvi. What Does It Mean for Ultragenyx (RARE)’s 2027 Profitability Target?

Yahoo Finance • 2 months ago

How Investors Are Reacting To Ultragenyx Pharmaceutical (RARE) First-In-Disease Gene Therapy Approval For FAYUVI

Yahoo Finance • 2 months ago

Andelyn and Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following FDA Approval of Ultragenyx's FAYUVITM to Treat Sanfilippo Syndrome Type A (MPS IIIA)

About

CEO
Dr. Emil D. Kakkis M.D., Ph.D.
CFO
Mr. Howard Horn
Address
60 Leveroni Court, Novato, CA, United States, 94949
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1,371